Eccogene files for Hong Kong IPO to back development of GLP-1 pipelinenews2025-10-08T14:50:39+00:00October 8th, 2025|Endpoints News|
Arthrosi raises $153M in Series E to complete two Phase 3 gout trialsnews2025-10-08T13:28:02+00:00October 8th, 2025|Endpoints News|
Soufflé Therapeutics, co-founded by Bob Langer, launches with $200Mnews2025-10-07T15:19:40+00:00October 7th, 2025|Endpoints News|
Mark Alles’ biotech gets $96M for ADCs from UCLA labnews2025-10-07T14:49:19+00:00October 7th, 2025|Endpoints News|
MapLight eyes $227M IPO as biopharma market warms upnews2025-10-07T05:10:35+00:00October 7th, 2025|Endpoints News|
BridgeBio’s GondolaBio bet skirts industry’s focus on small pipelinesnews2025-10-03T18:37:53+00:00October 3rd, 2025|Endpoints News|
Biotech IPOs in Hong Kong far outpace the US, driven by China’s buzzy biotech sectornews2025-10-02T14:39:04+00:00October 2nd, 2025|Endpoints News|
A year after collaborating with Gilead, Cartography maps out its own Phase 1 with $67M Series Bnews2025-10-02T11:30:35+00:00October 2nd, 2025|Endpoints News|
Gene therapy startup launches with $11M to tackle aging disease of the eyenews2025-10-02T11:00:20+00:00October 2nd, 2025|Endpoints News|
Halozyme to spend $750M upfront to buy Elektrofi, a biologics tech delivery companynews2025-10-01T14:43:46+00:00October 1st, 2025|Endpoints News|
